undamentalytics Newsletter
Sign in

Avita Medical, Inc. revenue

Avita Medical, Inc.'s revenue was $71.6m in fiscal 2025, up 11.5% on the year before. Since fiscal 2018 ($929,000) it has grown at a compound 86.0% a year. Over the last twelve months it was $75.6m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1514293450647276
Growth on the year before—+489.2%+160.6%+104.9%+17.8%+45.7%+28.1%+11.5%—
Gross profit0411232842555962
Gross margin41.2%76.8%79.2%79.6%82.4%84.5%85.8%82.1%81.6%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Recell Go Preparation Kit $35.8M ▲ 104.6%
Permeaderm $6M —

These categories overlap or exclude eliminations, so shares aren't shown.

Geography
Region Revenue Share YoY
United States $68.8M 96.1% ▲ 10.7%
Japan $2.1M 2.9% ▲ 45.9%
United Kingdom $486,000 0.7% ▲ 148.0%
Australia $200,000 0.3% ▼ 35.9%
European Union $49,000 0.1% ▼ 68.4%

From Avita Medical, Inc.'s 10-K filed February 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Avita Medical, Inc. $75.6m 1.0% 22.8%
Electromed, Inc. $73.8m 15.3% 15.4%
PRO DEX Inc $79.6m 13.3% 19.2%
Tela Bio, Inc. $79.9m 6.1% 17.6%
Sight Sciences, Inc. $83.4m 9.3% 0.8%
Pulmonx Corp $87.4m -3.4% 13.0%

Compare with peers

Head to head: ELMD vs RCELPDEX vs RCELRCEL vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Avita Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Avita Medical, Inc.